Osteocalcin, Bovine

Send Inquiry
Osteocalcin, Bovine
Details
Bovine osteocalcin;
Category: Osteogenic hormone / bone- and glucose-metabolism peptide.
Peptide Purity (HPLC) ≥95%
PTM Gla (γ-carboxyglutamate) modification
Structure Bone-derived peptide hormone (bovine Osteocalcin)
Solubility Dilute acetic acid/buffer
Storage Powder, −20°C, dry, light-protected
Category
Hormone Peptide
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of osteocalcin, bovine in China, also supports custom service. Welcome to wholesale bulk high quality osteocalcin, bovine from our factory. Contact us for more details.

 

  ↵

Description A Gla-containing osteoblast-derived bone protein whose undercarboxylated form acts as an endocrine hormone on insulin secretion, sensitivity and testosterone.

 

Product Basic Information Table

 

Standard English Name Abbreviation/Synonym Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Osteocalcin (bovine), no CAS Bovine osteocalcin; bone gamma-carboxyglutamic acid-containing protein; BGLAP; BGP; bOCN; PEP-OCNBV-01 bone matrix noncollagenous protein, vitamin K-dependent Gla protein, bone formation marker, hydroxyapatite binding, Cys23-Cys29 disulfide, acidic peptide, non-standard Gla residues Full-length 49-residue single-chain osteocalcin (bovine, Bos taurus; BGLAP/BGP). Three-letter sequence: H-Tyr-Leu-Asp-His-Trp-Leu-Gly-Ala-Pro-Ala-Pro-Tyr-Pro-Asp-Pro-Leu-Gla-Pro-Lys-Arg-Gla-Val-Cys-Gla-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val-OH. Standard-residue approximation (Gla shown as Glu): YLDHWLGAPAPYPDPLEPKREVCELNPDCDELADHIGFQEAYRRFYGPV. Positions 17, 21 and 24 are vitamin K-dependent gamma-carboxyglutamic acid (Gla/Z, non-standard residues); each Gla = Glu + CO2 (+43.99 Da, +C1O2), giving three Gla residues. An intramolecular disulfide joins Cys23 to Cys29; C-terminus is free acid, N-terminus not acetylated. Contains Trp×1, Tyr×3, Cys×2, and is acidic (pI ~4.0–4.6). The bovine mature sequence differs from human OCN at positions including 2, 3, 4, 10 and 19; do not mix species. C263H372N66O82S2 5830.64 5834.29 Calculated on the free-peptide main chain; this product has no CAS number and was verified by name plus bovine species. Native bone-derived preparations are often supplied in 50% glycerol/Tris-NaCl buffer, whereas catalog synthetic peptides are commonly free peptide or acetate/TFA salt; the actual salt form and buffer system are per lot COA. Counterions are excluded from the main-chain formula. 49

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-OCNBV-01 White to off-white powder (acidic hydrophilic peptide enriched in Gla carboxylates; TFA/acetate forms are hygroscopic - reseal immediately after opening, keep in a desiccator and weigh rapidly). Store sealed, desiccated and light-protected at −20°C; aliquot single-use portions to avoid repeated freeze-thaw. Contains two Cys in an intramolecular Cys23-Cys29 disulfide: reducing agents such as DTT/TCEP/β-mercaptoethanol are prohibited to prevent disulfide scrambling, cleavage or intermolecular aggregation. Contains Trp×1 and Tyr×3 - keep light-protected. As a 49-mer it is prone to aggregation, so reconstitution and freeze-thaw should be gentle. Gla carboxylates can decarboxylate under alkaline conditions; avoid pH>8. Protect the acidic peptide from moisture. Store dry and light-protected at 2–8°C; use within 2–4 weeks; store working aliquots frozen at −20°C, dark; ship sealed against moisture. Acidic 49-mer; soluble in water or weakly alkaline/neutral buffers (e.g., Tris buffer with low Ca²⁺, PBS pH 7.4). The Gla-rich segment is fairly hydrophilic; if poorly soluble, pre-dissolve in a small volume of dilute ammonia (<50 µL) or a little DMSO before diluting. Prepare 1–2 mg/mL; gentle vortexing or brief sonication may assist. After reconstitution: ≤1 week at 2–8°C; aliquot and freeze ≤3 months at −20°C; ≤3 freeze-thaw cycles; reconstitute slowly, add 0.02% Tween-20 if needed to prevent wall adsorption and aggregation; no DTT/TCEP/β-ME; avoid pH>8; keep solutions dark and avoid heat to prevent Gla decarboxylation. Dry-sealed, stable for at least 2 years at 2–8°C; longer-term storage at −20°C; keep moisture-, light- and oxidation-protected, and avoid alkaline conditions that cause Gla decarboxylation.

 

Functional Description

 

Product Code Front-end Short Summary Detailed Biological Function Research Areas (comma-separated) Targets / Receptors
PEP-OCNBV-01 Bovine osteocalcin (bOCN/BGLAP), a full-length 49-mer with no CAS number; contains three vitamin K-dependent Gla residues (17/21/24) and an intramolecular Cys23-Cys29 disulfide; free-peptide formula C263H372N66O82S2, MW 5830.64/5834.29. A noncollagenous bone-matrix protein secreted by osteoblasts that binds hydroxyapatite, regulates bone mineralization and serves as a bone-formation marker in bone-metabolism research. Osteocalcin (OCN/BGLAP, also bone Gla protein, BGP) is one of the most abundant noncollagenous bone-matrix proteins secreted by osteoblasts and belongs to the vitamin K-dependent Gla protein family; the bovine mature peptide is a 49-residue single chain. Cross-verified against MCE (HY-P10126, 49-mer, YLDHWLGAPAPYPDPL-Gla-PKR-Gla-VC-Gla-LNPDCDELADHIGFQEAYRRFYGPV, Cys23-Cys29 disulfide, formula C263H372N66O82S2, MW 5834.29), UniProt (P02820, Bos taurus BGLAP precursor, C-terminal 49-mer YLDHWLGAPAPYPDPLEPKREVCELNPDCDELADHIGFQEAYRRFYGPV), CellSystems (BOC-3020, 49 aa, Gla 17/21/24, Cys23-Cys29, Mr ≈5800, pI 4.0–4.6) and a PMC NMR structural study of bovine osteocalcin (calculated monomer MW ≈5850): this product is the full-length 49-mer (not a fragment), with three Gla at positions 17, 21 and 24 and one intramolecular disulfide. The dicarboxylated Gla side chains form a calcium-binding pocket that mediates hydroxyapatite/calcium binding and helps regulate bone mineralization rate; circulating osteocalcin reflects bone-formation rate and is a widely used marker in osteoporosis and metabolic bone-disease research. Undercarboxylated osteocalcin (ucOCN) also acts as an endocrine factor via receptors such as GPRC6A, influencing glucose/lipid metabolism, testosterone synthesis and muscle function. Applications include bone-formation and bone-metabolism mechanisms, osteoporosis and metabolic bone-disease models, vitamin K/carboxylation studies, hydroxyapatite binding and crystal-growth inhibition, osteocalcin receptor (GPRC6A) signaling, and the bone–endocrine axis. Note: Gla is a non-standard residue not included in this batch's residue table, so formula and MW are taken from external authoritative sources. A standard-residue approximation (Gla as Glu) plus 3×CO2 (+3C+6O, +131.97 Da mono) gives C263H372N66O82S2, mono 5830.64 / avg 5834.36, within ~0.07 Da of the MCE average MW 5834.29 (difference due to residue average-mass tables). The bovine sequence differs from human; do not mix species. bone metabolism and bone-formation marker, osteoporosis and metabolic bone-disease research, vitamin K-dependent carboxylation, hydroxyapatite binding and mineralization, GPRC6A and bone–endocrine axis, calcium/phosphate homeostasis Binds bone-matrix hydroxyapatite via the Gla calcium-binding pocket; undercarboxylated osteocalcin signals through GPRC6A (GPCR); a bone-formation marker secreted by osteoblasts

 

 

 

 

Hot Tags: osteocalcin, bovine, China osteocalcin, bovine manufacturers, suppliers, factory, 161748-29-4, 25696-21-3, 76461-17-1, ACTH 1 14 , CAS 76461 17 1, GLP 1 9 36 amide

Send Inquiry